同步与序贯放化疗治疗III期非小细胞肺癌的比较研究

Journal of cancer science and clinical therapeutics Pub Date : 2023-01-01 DOI:10.26502/jcsct.5079209

Aditi Paul Chowdhury, Md. Ruhul Amin Bhuiyan, Md. Ershadul Haque, Abdul Mannan, Abdullah Al Mamun

{"title":"同步与序贯放化疗治疗III期非小细胞肺癌的比较研究","authors":"Aditi Paul Chowdhury, Md. Ruhul Amin Bhuiyan, Md. Ershadul Haque, Abdul Mannan, Abdullah Al Mamun","doi":"10.26502/jcsct.5079209","DOIUrl":null,"url":null,"abstract":"Background: Non-small cell Lung carcinoma is the most common carcinoma in both worldwide and Bangladesh. Most of them presents with locally advanced disease. Though Concurrent Chemoradiation (CCRT) is the standard approach, Sequential chemoradiotherapy (SCRT) can also be considered in stage III NSCLC. This study’s aim is to compare the local control and toxicity of CCRT and SCRT in stage III NSCLC.","PeriodicalId":73634,"journal":{"name":"Journal of cancer science and clinical therapeutics","volume":"56 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Concurrent Versus Sequential Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer-A Comparative Study\",\"authors\":\"Aditi Paul Chowdhury, Md. Ruhul Amin Bhuiyan, Md. Ershadul Haque, Abdul Mannan, Abdullah Al Mamun\",\"doi\":\"10.26502/jcsct.5079209\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Non-small cell Lung carcinoma is the most common carcinoma in both worldwide and Bangladesh. Most of them presents with locally advanced disease. Though Concurrent Chemoradiation (CCRT) is the standard approach, Sequential chemoradiotherapy (SCRT) can also be considered in stage III NSCLC. This study’s aim is to compare the local control and toxicity of CCRT and SCRT in stage III NSCLC.\",\"PeriodicalId\":73634,\"journal\":{\"name\":\"Journal of cancer science and clinical therapeutics\",\"volume\":\"56 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of cancer science and clinical therapeutics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.26502/jcsct.5079209\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of cancer science and clinical therapeutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.26502/jcsct.5079209","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

背景:非小细胞肺癌是世界和孟加拉国最常见的癌症。他们大多表现为局部晚期疾病。虽然同步放化疗(CCRT)是标准的方法，顺序放化疗(SCRT)也可以考虑在III期NSCLC。本研究的目的是比较CCRT和SCRT治疗III期NSCLC的局部控制和毒性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Concurrent Versus Sequential Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer-A Comparative Study

Background: Non-small cell Lung carcinoma is the most common carcinoma in both worldwide and Bangladesh. Most of them presents with locally advanced disease. Though Concurrent Chemoradiation (CCRT) is the standard approach, Sequential chemoradiotherapy (SCRT) can also be considered in stage III NSCLC. This study’s aim is to compare the local control and toxicity of CCRT and SCRT in stage III NSCLC.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of cancer science and clinical therapeutics

自引率

0.00%

发文量